Ledger.Open graph →
SEC Form D · filed December 7, 2020

Scorpion Therapeutics, Inc

Offering
—
Sold
$147.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jean-Francois J. Formela · Boston, MADirectorArjun J. Goyal · Boston, MADirectorKeith J. Flaherty · Boston, MADirectorOtello J. Stampacchia · Boston, MADirectorShelley J. Chu · Boston, MADirectorPeter J. Campisi, Jr · BOSTON, MAExecGary Glick · Cambridge, MAExec · DirectorJean-Francois J. Formela · Boston, MADirectorArjun J. Goyal · Boston, MADirectorPeter J. Campisi, Jr · BOSTON, MAExecKeith J. Flaherty · Boston, MADirectorOtello J. Stampacchia · Boston, MADirectorShelley J. Chu · Boston, MADirectorGary Glick · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗